91 related articles for article (PubMed ID: 17019744)
1. A new cell-permeable calpain inhibitor.
Fiorino F; Gil-Parrado S; Assfalg-Machleidt I; Machleidt W; Moroder L
J Pept Sci; 2007 Jan; 13(1):70-3. PubMed ID: 17019744
[TBL] [Abstract][Full Text] [Related]
2. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
Gil-Parrado S; Assfalg-Machleidt I; Fiorino F; Deluca D; Pfeiler D; Schaschke N; Moroder L; Machleidt W
Biol Chem; 2003 Mar; 384(3):395-402. PubMed ID: 12715890
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of allosteric calpain-1 inhibitors populating a novel bioactivity space.
Kalash L; Cresser-Brown J; Habchi J; Morgan C; Miller DJ; Glen RC; Allemann RK; Bender A
Eur J Med Chem; 2018 Sep; 157():1264-1275. PubMed ID: 30195237
[TBL] [Abstract][Full Text] [Related]
4. [Calpain and calpastatin].
Murachi T
Rinsho Byori; 1990 Apr; 38(4):337-46. PubMed ID: 2195187
[TBL] [Abstract][Full Text] [Related]
5. Calpains: attractive targets for the development of synthetic inhibitors.
Pietsch M; Chua KC; Abell AD
Curr Top Med Chem; 2010; 10(3):270-93. PubMed ID: 20166953
[TBL] [Abstract][Full Text] [Related]
6. Potent peptide alpha-ketohydroxamate inhibitors of recombinant human calpain I.
Josef KA; Kauer FW; Bihovsky R
Bioorg Med Chem Lett; 2001 Oct; 11(19):2615-7. PubMed ID: 11551762
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics.
Low KE; Ler S; Chen KJ; Campbell RL; Hickey JL; Tan J; Scully CC; Davies PL; Yudin AK; Zaretsky S
J Med Chem; 2016 Jun; 59(11):5403-15. PubMed ID: 27148623
[TBL] [Abstract][Full Text] [Related]
8. Poly-arginine-fused calpastatin peptide, a living cell membrane-permeable and specific inhibitor for calpain.
Wu HY; Tomizawa K; Matsushita M; Lu YF; Li ST; Matsui H
Neurosci Res; 2003 Sep; 47(1):131-5. PubMed ID: 12941454
[TBL] [Abstract][Full Text] [Related]
9. Calpastatin subdomains A and C are activators of calpain.
Tompa P; Mucsi Z; Orosz G; Friedrich P
J Biol Chem; 2002 Mar; 277(11):9022-6. PubMed ID: 11809743
[TBL] [Abstract][Full Text] [Related]
10. Intracellular regulatory system involving calpain and calpastatin.
Murachi T
Biochem Int; 1989 Feb; 18(2):263-94. PubMed ID: 2548504
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT.
Betts R; Weinsheimer S; Blouse GE; Anagli J
J Biol Chem; 2003 Mar; 278(10):7800-9. PubMed ID: 12500971
[TBL] [Abstract][Full Text] [Related]
12. Cardiac high molecular weight calmodulin-binding protein is homologous to calpastatin I and calpastatin II.
Singh N; Shrivastav A; Olson D; Lakshmikuttyamma A; Ross A; Parr T; Bardsley RG; Sharma RK
Biochem Biophys Res Commun; 2008 Aug; 373(3):387-91. PubMed ID: 18572013
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of cell-penetrating conjugates of calpain activator peptides.
Banóczi Z; Tantos A; Farkas A; Tompa P; Friedrich P; Hudecz F
Bioconjug Chem; 2007; 18(1):130-7. PubMed ID: 17226965
[TBL] [Abstract][Full Text] [Related]
14. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
Hanna RA; Campbell RL; Davies PL
Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
[TBL] [Abstract][Full Text] [Related]
15. Local structural preferences of calpastatin, the intrinsically unstructured protein inhibitor of calpain.
Kiss R; Kovács D; Tompa P; Perczel A
Biochemistry; 2008 Jul; 47(26):6936-45. PubMed ID: 18537264
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of the yak gene coding for calpastatin and in silico analysis of its putative product.
Zhang L; Ma B; Wu J; Fei C; Yang L; Wan H
Acta Biochim Pol; 2010; 57(1):35-41. PubMed ID: 20300663
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors.
Donkor IO; Xu J; Liu J; Cameron K
Bioorg Med Chem; 2020 May; 28(9):115433. PubMed ID: 32199690
[TBL] [Abstract][Full Text] [Related]
18. The beta- and gamma-CH2 of B27-WT's Leu11 and Ile18 side chains play a direct role in calpain inhibition.
Betts R; Anagli J
Biochemistry; 2004 Mar; 43(9):2596-604. PubMed ID: 14992597
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
Pfizer J; Assfalg-Machleidt I; Machleidt W; Schaschke N
Biol Chem; 2008 Jan; 389(1):83-90. PubMed ID: 18095873
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel calpain inhibitor using phage display.
Guttmann RP; Day GA; Wang X; Bottiggi KA
Biochem Biophys Res Commun; 2005 Aug; 333(4):1087-92. PubMed ID: 15979564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
